Cardinal Health, Inc.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: US14149Y1082
USD
199.19
-0.52 (-0.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cardinal Health, Inc. stock-summary
stock-summary
Cardinal Health, Inc.
Retailing
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Company Coordinates stock-summary
Company Details
7000 Cardinal Pl , DUBLIN OH : 43017-1091
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 169 Schemes (36.25%)

Foreign Institutions

Held by 392 Foreign Institutions (19.38%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Gregory Kenny
Independent Non-Executive Chairman of the Board
Mr. Michael Kaufmann
Chief Executive Officer, Director
Ms. Carrie Cox
Independent Director
Mr. Calvin Darden
Independent Director
Mr. Bruce Downey
Independent Director
Ms. Sheri Edison
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
60,159 Million
(Quarterly Results - Jun 2025)
Net Profit:
243 Million
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 42,348 Million (Mid Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.68

stock-summary
Return on Equity

-62.80%

stock-summary
Price to Book

-15.23